About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
Sustainable development/ESG“We help people live healthy lives in a healthy world”. This is our mission, which reflects Polpharma’s priorities. We provide patients with high-quality, effective, safe and accessible products while operating responsibly in the society, the environment and with respect to key stakeholders.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
PRICE INQUIRY No. SEMA/63/PR108349/2025 – being conducted as a market assessment study13 June 2025In connection with the implementation of the project titled “Design and development of an innovative solution – a drug from the group of GLP-1 receptor… read more
Company News Markus Sieger takes the helm as President ad interim at Medicines for Europe12 June 2025Markus’ previous experience in Medicines for Europe spans the range of priority topics for our sector, including the EU pharmaceutical legislation, Critical Medicines Act, the… read more
Company News Other Polpharma Group Supports Urgent EU Action to Safeguard Access to Medicines and Strengthen European Pharmaceutical Sovereignty04 June 2025The letter, signed by CEOs and senior executives from across the European off-patent medicines sector, focuses on the need to: Accelerate the adoption of the… read more
PRICE INQUIRY No. JODO/26/PR97811/2025 – being conducted as a market assessment study30 May 2025In connection with the implementation of the project titled “Development and introduction to the medical market of the first non-antibiotic product in the treatment of… read more
PRICE INQUIRY No. SEMA/62/PR108349/2025 – being conducted as a market assessment study27 May 2025In connection with the implementation of the project titled “Design and development of an innovative solution – a drug from the group of GLP-1 receptor… read more
